AiM Medical to integrate robotic neurosurgery system with Siemens’ MRI

Partnerships
АiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM’s robotic neurosurgery platform to integrate with Siemens Healthineers’ magnetic resonance imaging (MRI) systems. The collaboration focuses...

AiM Medical to integrate robotic neurosurgery system with Siemens’ MRI

Partnerships
АiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM’s robotic neurosurgery platform to integrate...

Neurovalens earns FDA nod for neuromod for PTSD

Regulatory Approvals
Neurovalens announced that it received FDA de novo approval for Modius Spero, a post-traumatic stress disorder (PTSD) therapy. Belfast, Northern Ireland-based Neurovalens designed its Modius...

Baymatob raises $6.5M to predict birth complications before they happen

Funding
Australian medtech startup Oli has raised $6.5 million in a Series A3 funding round to accelerate the development of its maternal and fetal monitoring...

Olympus agrees $270M BioProtect buyout to expand prostate cancer offerings

Mergers & Acquisitions
Olympus has agreed to acquire BioProtect in a $270m deal, giving the company a commercial device that will help expand its prostate cancer care...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Reflow Medical has positive data for coronary drug-eluting stent

Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its...

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

Innovation

Regulatory Approvals

AiM Medical to integrate robotic neurosurgery system with Siemens’ MRI

АiM Medical Robotics (AiM) has signed an agreement with Siemens Healthineers to develop an interface that will allow AiM’s robotic neurosurgery platform to integrate...

Neurovalens earns FDA nod for neuromod for PTSD

Neurovalens announced that it received FDA de novo approval for Modius Spero, a post-traumatic stress disorder (PTSD) therapy. Belfast, Northern Ireland-based Neurovalens designed its Modius...

Baymatob raises $6.5M to predict birth complications before they happen

Australian medtech startup Oli has raised $6.5 million in a Series A3 funding round to accelerate the development of its maternal and fetal monitoring...

Olympus agrees $270M BioProtect buyout to expand prostate cancer offerings

Olympus has agreed to acquire BioProtect in a $270m deal, giving the company a commercial device that will help expand its prostate cancer care...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1141Regulatory Approvals1018Innovation655Clinical Trials522Mergers & Acquisitions509GS Funding Tracker50